Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
BMC Geriatr ; 20(1): 451, 2020 11 05.
Article in English | MEDLINE | ID: mdl-33153458

ABSTRACT

BACKGROUND: McArdle disease is a myopathy caused by mutations in PYGM gene that is characterized by reduced or absent activity of myophosphorylase. Reports of patients with concomitant McArdle disease and diabetes are scarce. We report a case of a patient with a late diagnosis of McArdle disease and we postulate that symptoms may be related to hypoinsulinemia. CASE PRESENTATION: This report describes the evolution of an elderly diabetic patient with confirmed diagnosis of McArdle's disease based on the absence of myophosphorylase activity in the analysis of muscle biopsy, and a homozygous mutation in the PYGM gene. The variant - Chr11: 64.525 (p. Asn168*fs) has not been previously described. The diagnosis of McArdle disease was confirmed after two episodes of rhabdomyolysis, at 77 and 81 years of age, as the symptoms were, until then, discrete. The "second-wind phenomenon" was not spontaneously reported, but it was confirmed when directly questioned. We postulate that the later episodes of rhabdomyolysis occurred because of a progressive decrease in insulin production with a consequent reduction in the uptake of blood glucose by muscle cells, thus compromising the cellular energy balance. To our knowledge, this is the first report of recurrent rhabdomyolysis in an elderly diabetic patient with genetically proven McArdle disease. Our initial attempt to reduce insulin resistance with metformin and pioglitazone was not effective, possibly because of inadequate insulinemia. However, an improvement was evident after the administration of low doses of intermediate-acting insulin. CONCLUSIONS: In view of the patient's clinical evolution, we suggest the use of medication that reduces insulin resistance for patients with McArdle disease and type 2 diabetes, pre-diabetes or even normoglycemic metabolic syndrome.


Subject(s)
Diabetes Mellitus, Type 2 , Glycogen Phosphorylase, Muscle Form , Glycogen Storage Disease Type V , Rhabdomyolysis , Aged , Glycogen Phosphorylase, Muscle Form/genetics , Glycogen Storage Disease Type V/complications , Glycogen Storage Disease Type V/diagnosis , Glycogen Storage Disease Type V/genetics , Humans , Mutation , Rhabdomyolysis/complications , Rhabdomyolysis/diagnosis , Rhabdomyolysis/genetics
2.
PLoS One ; 15(7): e0236597, 2020.
Article in English | MEDLINE | ID: mdl-32735634

ABSTRACT

INTRODUCTION: McArdle disease presents clinical and genetic heterogeneity. There is no obvious association between genotype and phenotype. PYGM (muscle glycogen phosphorylase gene) mRNA expression and its association with clinical, morphological, and genetic aspects of the disease as a set have not been studied previously. METHODS: We investigated genetic variation in PYGM considering the number of PTCs (premature termination codon) per sample and compared mRNA expression in skeletal muscle samples from 15 patients with McArdle disease and 16 controls to PTCs number and different aspects of the disease. RESULTS: The main variant found was c.148C>T (PTC-premature termination codon). Patients with two PTCs showed 42% mRNA expression compared to the control group. Most cases showed an inversely proportional relation among PTCs and mRNA expression. Association between mRNA expression and other aspects of the disease showed no statistically significant difference (p> 0.05). DISCUSSION: mRNA expression is not useful as a predictor factor for the prognosis and severity of the disease. Different mechanisms as post-transcriptional events, epigenetics factors or protein function may be involved.


Subject(s)
Demography , Gene Expression Regulation, Enzymologic , Glycogen Phosphorylase, Muscle Form/genetics , Glycogen Storage Disease Type V/genetics , Adult , Codon, Nonsense/genetics , Cross-Sectional Studies , Female , Glycogen Storage Disease Type V/epidemiology , Glycogen Storage Disease Type V/pathology , Humans , Male , Middle Aged , RNA, Messenger/genetics , Young Adult
3.
Acta Neurol Belg ; 120(2): 303-311, 2020 Apr.
Article in English | MEDLINE | ID: mdl-30415384

ABSTRACT

McArdle disease (MD) is a metabolic myopathy caused by deficiency of the myophosphorylase enzyme. The aim of our study was to analyse a series of MD patients in Brazil and the correlation between clinical findings, laboratory data, electromyography, muscle biopsy and genetic features. The PYGM gene was analysed by PCR/RLFP and Sanger sequencing. The sample included 12 patients, aged 18-57 years, from unrelated families. Exercise intolerance was present in all cases. Serum creatine kinase levels at rest were increased in all patients. Forearm ischaemic exercise testing in five patients revealed no increase in venous lactate. Needle electromyography presented 'myopathic pattern' in six patients. Muscle biopsy showed vacuolar myopathy in 10 patients and deficiency of myophosphorylase enzyme in all patients. The genetic analysis showed p.R50X as the most common mutation (allelic frequency: 56.25%), other known mutations (p.Y574X, p.G205S, p.W798R, IVS14 + 1G > A and IVS19-1G > A) and a new mutation (p.Asn168Lysfs*15) were also identified. Several features of the disorder were similar to the vast majority of patients worldwide. The genetic findings of this study revealed a range of mutations that are quite similar to the European cohort. The discovery of one novel mutation increases the genotypic heterogeneity of PYGM gene.


Subject(s)
Glycogen Storage Disease Type V/pathology , Glycogen Storage Disease Type V/physiopathology , Adolescent , Adult , Brazil , Female , Genotype , Glycogen Phosphorylase, Muscle Form/genetics , Glycogen Storage Disease Type V/genetics , Humans , Male , Middle Aged , Mutation , Phenotype , Young Adult
5.
Genet Mol Res ; 15(3)2016 Jul 29.
Article in English | MEDLINE | ID: mdl-27525900

ABSTRACT

Chronic fatigue syndrome (CFS) is a disease that can seriously impair one's quality of life; patients complain of excessive fatigue and myalgia following physical exertion. This disease may be associated with abnormalities in genes affecting exercise tolerance and physical performance. Adenosine monophosphate deaminase (AMPD1), carnitine palmitoyltransferase II (CPT2), and the muscle isoform of glycogen phosphorylase (PYGM) genes provide instructions for producing enzymes that play major roles in energy production during work. The aim of this study was to look for evidence of genotype-associated excessive muscle fatigue. Three metabolic genes (AMPD1, CPT2, and PYGM) were therefore fully sequenced in 17 Italian patients with CFS. We examined polymorphisms known to alter the function of these metabolic genes, and compared their genotypic distributions in CFS patients and 50 healthy controls using chi-square tests and odds ratios. One-way analysis of variance with F-ratio was carried out to determine the associations between genotypes and disease severity using CF scores. No major genetic variations between patients and controls were found in the three genes studied, and we did not find any association between these genes and CFS. In conclusion, variations in AMPD1, CPT2, and PGYM genes are not associated with the onset, susceptibility, or severity of CFS.


Subject(s)
AMP Deaminase/genetics , Carnitine O-Palmitoyltransferase/genetics , Fatigue Syndrome, Chronic/genetics , Glycogen Phosphorylase, Muscle Form/genetics , AMP Deaminase/metabolism , Adolescent , Adult , Carnitine O-Palmitoyltransferase/metabolism , Case-Control Studies , Fatigue Syndrome, Chronic/enzymology , Female , Gene Expression , Genetic Association Studies , Genetic Predisposition to Disease , Glycogen Phosphorylase, Muscle Form/metabolism , Humans , Male , Middle Aged , Polymorphism, Genetic , Young Adult
6.
Neuromolecular Med ; 15(3): 470-5, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23653251

ABSTRACT

McArdle's disease, a glycogen storage disease type V, is caused by a deficiency of the enzyme myophosphorylase, encoded by the PYGM gene. Worldwide distribution of mutations has revealed interesting data about the prevalence of mutations and population migrations. Currently, more than 100 mutations in the PYGM gene have been described, with some recurrent mutations in the different populations. However, no molecular studies of McArdle's disease were reported in Brazilian patients. Here, we describe the clinical phenotype and genotype of 10 patients from 8 unrelated Brazilian families. Among the 10 patients (3 females, 7 males), eight presented with the typical phenotype, with exercise intolerance, cramps, and myalgia; one patient showed permanent muscle weakness; and one patient showed a mild phenotype. Molecular analysis identified 5 different mutations in the 8 families, both in homozygosis or compound heterozygosis state. Four of them had already been described (p.R50X, p.T692kfs30, p.K609K, and p.G455R), and one, pI513V, is a novel heterozygous mutation. The common nonsense p.R50X mutation was found in 6 of the 8 families, being therefore the commonest mutation in the Brazilian population as well. Other mutations previously reported in European patients were also found in the patients in this study, which was expected considering the European ancestry of the Brazilian population.


Subject(s)
Glycogen Phosphorylase, Muscle Form/genetics , Glycogen Storage Disease Type V/genetics , Mutation , Adolescent , Adult , Aged , Amino Acid Sequence , Biopsy , Brazil/epidemiology , Codon, Nonsense , Electromyography , Europe/ethnology , Exercise Tolerance , Female , Genotype , Glycogen Phosphorylase, Muscle Form/chemistry , Glycogen Phosphorylase, Muscle Form/deficiency , Glycogen Storage Disease Type V/ethnology , Humans , Male , Middle Aged , Molecular Sequence Data , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Mutation, Missense , Myoglobinuria/genetics , Phenotype , Sequence Analysis, DNA , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL